Creative Medical Technology Holdings Inc (CELZ)
4.42
+0.08
(+1.84%)
USD |
NASDAQ |
May 17, 16:00
4.42
0.00 (0.00%)
After-Hours: 20:00
Creative Medical Technology Holdings Cash from Investing (TTM): 4.928M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 4.928M |
December 31, 2023 | 3.445M |
September 30, 2023 | -2.738M |
June 30, 2023 | -9.581M |
March 31, 2023 | -5.041M |
December 31, 2022 | -10.08M |
September 30, 2022 | -4.821M |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | -0.45M |
June 30, 2021 | -0.25M |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | 0.00 |
June 30, 2017 | -0.11M |
March 31, 2017 | -0.01M |
December 31, 2016 | -0.01M |
September 30, 2016 | -0.01M |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-10.08M
Minimum
Dec 2022
4.928M
Maximum
Mar 2024
-2.049M
Average
-0.35M
Median
Cash from Investing (TTM) Benchmarks
Avid Bioservices Inc | -51.17M |
Viking Therapeutics Inc | -641.08M |
Avinger Inc | -0.008M |
Aptevo Therapeutics Inc | 0.00 |
Absci Corp | 32.56M |